These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 17906197)
1. The graying of testis cancer patients: what have we learned? Bajorin DF J Clin Oncol; 2007 Oct; 25(28):4341-3. PubMed ID: 17906197 [No Abstract] [Full Text] [Related]
2. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202 [TBL] [Abstract][Full Text] [Related]
3. [Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis]. Bokemeyer C; Kuczyk MA; Köhne CH; Haupt A; Schmoll HJ Med Klin (Munich); 1996 Nov; 91(11):703-10. PubMed ID: 9036294 [No Abstract] [Full Text] [Related]
4. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma]. van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593 [TBL] [Abstract][Full Text] [Related]
5. Survivorship and complications of treatment in breast cancer. Mrozek E; Shapiro CL Clin Adv Hematol Oncol; 2005 Mar; 3(3):211-22, 238. PubMed ID: 16166992 [TBL] [Abstract][Full Text] [Related]
6. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732 [TBL] [Abstract][Full Text] [Related]
7. Late effects of treatment for germ cell tumors during childhood and adolescence. Hale GA; Marina NM; Jones-Wallace D; Greenwald CA; Jenkins JJ; Rao BN; Luo X; Hudson MM J Pediatr Hematol Oncol; 1999; 21(2):115-22. PubMed ID: 10206457 [TBL] [Abstract][Full Text] [Related]
9. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318 [TBL] [Abstract][Full Text] [Related]
10. Short- and long-term complications of therapy for testicular cancer. Kaufman MR; Chang SS Urol Clin North Am; 2007 May; 34(2):259-68; abstract xi. PubMed ID: 17484931 [TBL] [Abstract][Full Text] [Related]
11. Late complications of therapy of Hodgkin's disease: prevention and management. Ng AK; Mauch PM Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846 [TBL] [Abstract][Full Text] [Related]
12. Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center. Whitmore WF; Bosl G Acta Urol Belg; 1985; 53(2):341-61. PubMed ID: 2990181 [No Abstract] [Full Text] [Related]
13. Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure? von der Maase H Acta Oncol; 2005; 44(6):523-5. PubMed ID: 16165909 [No Abstract] [Full Text] [Related]